VALN (VALN) Stock Price & Analysis
VALN (VALN) fell 2.48% to USD 6.68 as of September 9, 2026 at 22:52 UTC, according to Nexqual real-time market data.
VALN last closed at USD 6.68; the session ranged USD 6.68–6.88 on volume of 24,118 shares. Market capitalization is —, with a 52-week range of USD 4.75–12.23 (NMS). Source: Nexqual, September 9, 2026 at 22:52 UTC.
Key Statistics (as of September 9, 2026 at 22:52 UTC)
| Price | USD 6.68 |
|---|---|
| Change | ▼ 2.48% (down) |
| Previous Close | USD 6.68 |
| Open | USD 6.68 |
| Day Range | USD 6.68 – 6.88 |
| 52-Week Range | USD 4.75 – 12.23 |
| Volume | 24,118 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (VALN)
Nexqual's technical model rates VALN "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 9, 2026 at 22:52 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.35 (neutral) |
| vs SMA50 | Above (USD 5.74) |
| MACD | 0.31 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MOLN | Molecular Partners AG | USD 4.35 | ▲ 0% |
| IPHA | Innate Pharma S.A. | USD 1.95 | ▼ 6.25% |
| PHVS | Pharvaris N.V. | USD 37.74 | ▲ 7.06% |
| LYEL | Lyell Immunopharma, Inc. | USD 12.88 | ▼ 10.37% |
| TYRA | Tyra Biosciences, Inc. | USD 22.01 | ▼ 23.18% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 22:52 UTC. This page is informational and not investment advice.